Literature DB >> 6642669

Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions.

M S Ascher, J C Williams, M A Berman.   

Abstract

Dermal granulomatous reactivity to Q fever antigens in guinea pigs has been described as a model for vaccine reactions seen in previously sensitized humans. This model has now been applied to study the ability of subfractions of Coxiella burnetii to produce granulomas. Q fever organisms in phase I, trichloroacetic acid-soluble and -insoluble fractions, and the extract and residue of chloroform-methanol extraction were tested for their relative ability to elicit and immunize for dermal granulomatous reactions and specific lymphocyte proliferative responses in guinea pigs. The results suggest that a determinant(s) causing granulomas can be removed by chloroform-methanol extraction of phase I whole cells. The chloroform-methanol residue elicited strong delayed-type hypersensitivity without subsequent granuloma formation. The chloroform-methanol residue appears to possess a determinant(s) for lymphocyte stimulation equivalent to that of whole phase I organisms.

Entities:  

Mesh:

Year:  1983        PMID: 6642669      PMCID: PMC264382          DOI: 10.1128/iai.42.3.887-889.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Preparation of phase 1Q fever antigen suitable for vaccine use.

Authors:  D S Spicer; A N DeSanctis
Journal:  Appl Environ Microbiol       Date:  1976-07       Impact factor: 4.792

2.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

3.  Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans.

Authors:  M S Ascher; M A Berman; R Ruppanner
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

4.  Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.

Authors:  J C Williams; J L Cantrell
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Q-fever soluble vaccine effects in Coxiella burneti sensitized humans.

Authors:  E Crăcea; S Dumitrescu-Constantinescu; D Botez; L Ioanid
Journal:  Zentralbl Bakteriol Orig A       Date:  1977-07

6.  Experimental model for dermal granulomatous hypersensitivity in Q fever.

Authors:  M S Ascher; M A Berman; D Parker; J L Turk
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Authors:  M S Ascher; P B Jahrling; D G Harrington; R A Kishimoto; V G McGann
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

8.  CONVERSION OF THE PHASE I ANTIGEN OF COXIELLA BURNETII TO HAPTEN BY PHENOL TREATMENT.

Authors:  R L ANACKER; W T HASKINS; D B LACKMAN; E RIBI; E G PICKENS
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

  8 in total
  7 in total

1.  Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.

Authors:  L F Fries; D M Waag; J C Williams
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

Review 2.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

3.  Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.

Authors:  J C Williams; T A Damrow; D M Waag; K Amano
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

4.  Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.

Authors:  James R Deringer; Chen Chen; James E Samuel; Wendy C Brown
Journal:  Microbiology (Reading)       Date:  2010-10-28       Impact factor: 2.777

5.  Standardized guinea pig model for Q fever vaccine reactogenicity.

Authors:  Laurie A Baeten; Brendan K Podell; Ann E Sluder; Anja Garritsen; Richard A Bowen; Mark C Poznansky
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

6.  Coxiella burnetii Whole Cell Vaccine Produces a Th1 Delayed-Type Hypersensitivity Response in a Novel Sensitized Mouse Model.

Authors:  Alycia P Fratzke; Anthony E Gregory; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

7.  Murine Q Fever Vaccination Model Reveals Sex Dimorphism in Early Phase Delayed-Type Hypersensitivity Responses.

Authors:  Picabo Binette; Mahelat Tesfamariam; Diane Cockrell; Robert A Heinzen; Crystal Richards; Carl Shaia; Carrie Mae Long
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.